New Triglucored Forte Tablet

Description

New Triglucored Forte Tablet is a prescription medicine used for the management of type 2 diabetes mellitus. It combines three antidiabetic agents for better blood sugar control:

• Glibenclamide (5mg): A sulfonylurea that stimulates insulin secretion from the pancreas.

• Metformin (500mg): A biguanide that reduces glucose production in the liver and improves insulin sensitivity.

• Pioglitazone (15mg): A thiazolidinedione that enhances insulin sensitivity in peripheral tissues.

 Highlighted Uses:

• Management of type 2 diabetes mellitus when diet, exercise, and monotherapy are insufficient

• Helps lower blood sugar levels effectively by combining three mechanisms of action

• Improves glycemic control and reduces risk of diabetes-related complications

How to Use:

• Take the tablet orally as prescribed, usually once daily or as directed by your doctor.

• Swallow whole with water, preferably after meals to reduce gastrointestinal discomfort.

Dosage:

• The dose is individualized based on blood sugar levels, response to therapy, and other medical conditions.

• Do not adjust or stop the medication without consulting your doctor.

Precautions:

• Inform your doctor if you have kidney, liver, or heart disease.

• Regular monitoring of blood glucose and HbA1c levels is recommended.

• Be cautious of hypoglycemia, especially when combined with other antidiabetic drugs.

• Use with caution during pregnancy or breastfeeding.

Possible Side Effects:

• Hypoglycemia (low blood sugar)

• Nausea, vomiting, diarrhea, or abdominal discomfort

• Weight gain or fluid retention

• Rare: liver dysfunction, heart failure, or allergic reactions